Title:
TREATMENT AGENT AND PHARMACEUTICAL COMPOSITION FOR GLIOMA
Document Type and Number:
WIPO Patent Application WO/2019/235570
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing a treatment agent and a pharmaceutical composition that are for effective prevention or treatment of glioma. The present invention provides a treatment agent for glioma, the treatment agent including a compound represented by general formula (1) or a salt thereof.
More Like This:
Inventors:
ISHII YUKIKO (JP)
KONDO TORU (JP)
KONDO TORU (JP)
Application Number:
PCT/JP2019/022538
Publication Date:
December 12, 2019
Filing Date:
June 06, 2019
Export Citation:
Assignee:
FUJIFILM CORP (JP)
UNIV HOKKAIDO NAT UNIV CORP (JP)
UNIV HOKKAIDO NAT UNIV CORP (JP)
International Classes:
A61K31/4725; A61K31/416; A61K31/4418; A61K31/4439; A61K31/4704; A61P35/00
Domestic Patent References:
WO2014069510A1 | 2014-05-08 | |||
WO2009021696A1 | 2009-02-19 | |||
WO2014069510A1 | 2014-05-08 |
Foreign References:
JP2010520268A | 2010-06-10 | |||
JP2002540103A | 2002-11-26 | |||
JP2001302667A | 2001-10-31 | |||
JP2010504298A | 2010-02-12 |
Other References:
STEM CELLS, vol. 34, no. 8, August 2016 (2016-08-01), pages 2016 - 25
BENJAMIN BADERWOLFGANG KNECHTMARKUS FRIESMONIKA LOFFLER: "Expression, Purification, and Characterization of Histidine-Tagged Rat and Human Flavoenzyme Dihydroorotate Dehydrogenase", PROTEIN EXPRESSION AND PURIFICATION, vol. 13, 1998, pages 414 - 422, XP004445222, DOI: 10.1006/prep.1998.0925
BENJAMIN BADERWOLFGANG KNECHTMARKUS FRIESMONIKA LOFFLER: "Expression, Purification, and Characterization of Histidine-Tagged Rat and Human Flavoenzyme Dihydroorotate Dehydrogenase", PROTEIN EXPRESSION AND PURIFICATION, vol. 13, 1998, pages 414 - 422, XP004445222, DOI: 10.1006/prep.1998.0925
Attorney, Agent or Firm:
SIKS & CO. (JP)
Download PDF:
Previous Patent: KINASE INHIBITOR
Next Patent: TREATMENT AGENT AND PHARMACEUTICAL COMPOSITION FOR HEMATOLOGIC CANCER
Next Patent: TREATMENT AGENT AND PHARMACEUTICAL COMPOSITION FOR HEMATOLOGIC CANCER